Crossmark

Comparative efficacy and safety of extended adjuvant endocrine therapy for hormone receptor-positive early breast cancer: a Bayesian network meta-analysis

Crossref DOI link: https://doi.org/10.1007/s10549-023-07105-9

Published Online: 2023-10-03

Published Print: 2024-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

He, Peng

Li, Jing

Chen, Minyan

Huang, Meng

Qiu, Yibin

Cai, Qindong

Lin, Yuxiang

Wang, Chuan

Fu, Fangmeng https://orcid.org/0000-0002-3065-5708
License Information

Text and Data Mining valid from 2023-10-03

Version of Record valid from 2023-10-03
More Information

Article History

Received: 22 March 2023

Accepted: 23 August 2023

First Online: 3 October 2023

Declarations

:

: The authors declare no competing interest.

Document is current

Any future updates will be listed below